| Authors: |
Takeda DY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; The Eli and Edythe L. Broad Institute, Cambridge, MA 02142, USA., Spisák S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Bell C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., O'Connor E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Korthauer K; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA; Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Ribli D; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest 1117, Hungary., Csabai I; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Pázmány P. s. 1A, Budapest 1117, Hungary., Solymosi N; Centre for Bioinformatics, University of Veterinary Medicine, István str. 2, Budapest 1078, Hungary., Szállási Z; Computational Health Informatics Program (CHIP) Boston Children's Hospital Harvard Medical School, Boston, MA 02215, USA; Danish Cancer Society Research Center, Strandboulevarden 49, 2100 Copenhagen, Denmark; 2nd Department of Pathology, MTA-SE NAP, Brain Metastasis Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest 1091, Hungary., Stillman DR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Cejas P; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Qiu X; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Long HW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Tisza V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Computational Health Informatics Program (CHIP) Boston Children's Hospital Harvard Medical School, Boston, MA 02215, USA., Nuzzo PV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Lgo R. Benzi 10, 16132, Italy., Rohanizadegan M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA 02115, USA., Pomerantz MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; The Eli and Edythe L. Broad Institute, Cambridge, MA 02142, USA., Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; The Eli and Edythe L. Broad Institute, Cambridge, MA 02142, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address: mfreedman@partners.org. |
